STOMACH CANCER

This is an early-stage study testing the safety of a new type of CAR-T cell therapy called PTC13 in adults with advanced solid tumors that have a marker called CEA. The therapy involves collecting a patient's own immune cells, genetically engineering them in a lab to better targe…

This study is testing a new experimental drug called 3H-10000 in people with advanced lung or stomach cancer that cannot be removed by surgery or has spread. The main goals are to find a safe and effective dose and to see if the drug can shrink tumors. The study will enroll about…

This study is testing whether adding a new drug called ivonescimab to standard chemotherapy (FOLFOX) works better for people with advanced stomach or esophagus cancer that is HER2-negative. The goal is to see if this combination can help control the cancer for longer and shrink t…

This study is testing whether two oral drugs, avutometinib and defactinib, can help people with a specific, hard-to-treat type of advanced stomach cancer live longer without their cancer getting worse. The trial is for adults whose cancer has spread or cannot be removed by surger…

This study is testing a new robotic surgery system designed to help surgeons operate on stomach cancer. Ten patients in Hong Kong and Japan will have their cancer removed using this experimental robot with an extra 'fifth arm' for assistance. The main goal is to see if the proced…

This early-stage trial is testing a new drug called CA-4948 in combination with standard chemotherapy and immunotherapy for people with advanced stomach or esophageal cancer that cannot be surgically removed. The study aims to find the safest dose of this combination and see if i…

This study is testing new radioactive tracer chemicals for PET/CT scans to see if they can better detect and monitor cancers of the digestive system, including stomach, colon, liver, and pancreatic cancer. About 400 adults with confirmed or suspected digestive cancer will receive…

This study is testing a new blood test designed to detect many types of cancer early, before symptoms appear. It will involve 7,000 people, both with and without cancer, to see if the test can accurately spot cancer signals and identify where in the body the cancer started. The t…

This study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…

This study aims to understand how genes and proteins contribute to the development of stomach and esophageal cancers. Researchers will analyze tissue samples from biopsies and blood samples from 100 participants who either have these cancers or are at high inherited risk. The goa…

This study aims to see if changes in what people buy—like pain relief or digestive aids—can serve as an early warning sign for certain cancers. Researchers will compare the shopping history of 1,450 recently diagnosed cancer patients with 1,450 people without cancer, using up to …